看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -24.7x - -27.3x | -26.0x |
| Selected Fwd P/E Multiple | -1,197.4x - -1,323.4x | -1,260.4x |
| Fair Value | $61.59 - $68.08 | $64.83 |
| Upside | -33.7% - -26.7% | -30.2% |
| Benchmarks | - | Full Ticker |
| Sight Sciences, Inc. | - | NasdaqGS:SGHT |
| Nova Eye Medical Limited | - | OTCPK:ELXM.F |
| Alcon Inc. | - | NYSE:ALC |
| Koninklijke Philips N.V. | - | NYSE:PHG |
| CVRx, Inc. | - | NasdaqGS:CVRX |
| Glaukos Corporation | - | NYSE:GKOS |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| SGHT | ELXM.F | ALC | PHG | CVRX | GKOS | |||
| NasdaqGS:SGHT | OTCPK:ELXM.F | NYSE:ALC | NYSE:PHG | NasdaqGS:CVRX | NYSE:GKOS | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | 39.4% | NM- | NM- | NM- | ||
| Latest Twelve Months | 7.3% | 40.2% | 4.5% | -85.1% | -45.5% | -8.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -102.8% | 1.1% | 2.9% | 2.6% | -204.0% | -33.2% | ||
| Prior Fiscal Year | -68.5% | -89.8% | 10.3% | -2.5% | -104.8% | -42.8% | ||
| Latest Fiscal Year | -64.5% | -37.7% | 10.3% | -4.7% | -116.9% | -38.2% | ||
| Latest Twelve Months | -64.5% | -32.8% | 10.3% | -4.7% | -116.9% | -38.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -0.8x | -5.2x | 18.9x | 14.6x | -1.8x | -69.5x | ||
| Price / LTM Sales | 1.5x | 1.1x | 4.4x | 1.0x | 3.2x | 13.7x | ||
| LTM P/E Ratio | -2.4x | -3.3x | 43.1x | -22.4x | -2.7x | -35.9x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -22.4x | -2.7x | 43.1x | |||||
| Historical LTM P/E Ratio | -54.3x | -35.9x | -23.2x | |||||
| Selected P/E Multiple | -24.7x | -26.0x | -27.3x | |||||
| (x) LTM Net Income | (146) | (146) | (146) | |||||
| (=) Equity Value | 3,612 | 3,802 | 3,992 | |||||
| (/) Shares Outstanding | 56.5 | 56.5 | 56.5 | |||||
| Implied Value Range | 63.89 | 67.25 | 70.61 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 63.89 | 67.25 | 70.61 | 92.91 | ||||
| Upside / (Downside) | -31.2% | -27.6% | -24.0% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | SGHT | ELXM.F | ALC | PHG | CVRX | GKOS | |
| Value of Common Equity | 124 | 57 | 44,802 | 19,376 | 170 | 5,253 | |
| (/) Shares Outstanding | 51.3 | 358.5 | 494.6 | 925.0 | 26.0 | 56.5 | |
| Implied Stock Price | 2.41 | 0.16 | 90.58 | 20.95 | 6.53 | 92.91 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.58 | 1.00 | 0.88 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2.41 | 0.10 | 90.58 | 23.79 | 6.53 | 92.91 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.58 | 1.00 | 0.88 | 1.00 | 1.00 | |